** Shares of the drug maker Viatris VTRS.O rise about 2.6% to $7.82 premarket
** Co says would pay up to $335 mln over nine years as part of a nationwide settlement to resolve opioid related claims
** VTRS to pay between $27.5 mln to $40 mln annually toward state and local opioid initiatives
** As of last close, stock down 38.8% YTD
(Reporting by Sruthi Narasimha Chari in Bengaluru)
((Sruthinarasimha.chari@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。